Categories
Recent Posts
- RoZetta’s global commercialisation success story continues with sale of Lorica Health
- When High-frequency Traders Stay Isolated For COVID-19
- The “end” of roaring 2010’s yield-enhancing strategies – a Buy-Side perspective
- Measuring the influence of COVID-19 on the Australian property sector
- How RoZetta Institute research limits the impact of flash crashes